Abstract
Despite the results from clinical trials in patients with hypertension and the development of a long list of guidelines for the management of hypertension, many physicians and other healthcare professionals still manage hypertension using approaches that clearly diverge at least partially from the recommendations of these guidelines. Whatever the underlying reasons for physicians’ failure to adhere to these guidelines, it is one of the main causes of the high percentage of treated patients with uncontrolled hypertension. This article is a report of the out-comes of a project designed to identify specific discrepancies between hypertension guidelines and clinical practice in Italy then guide the physicians to reach a consensus on hypertension management through discussions with their peers. A total of 1120 internists from all 20 regions in Italy were recruited to participate in workshops conducted between June 2002 and July 2004. They were divided into 57 groups to discuss at least 7 key topics, including the blood pressure level at which to start drug therapy, target-organ damage, isolated systolic hypertension, pulse pressure, clinical trials, generic drugs, and fixed combination drug therapy. The project findings confirmed that the vast majority of internists agree with the guidelines but do not adhere to them completely in clinical practice. Through open discussions that allowed them to identify common viewpoints, the participants may have developed a better awareness of and insight into the guidelines for hypertension management. Hopefully this strategy for group participation will lead to improvements in the management of hypertension throughout Italy.
Similar content being viewed by others
References
Reaven G. Insulin resistance, hypertension, and coronary heart disease.J Clin Hypertens. 2003; 5:269–274.
Blood Pressure Lowering Treatment Trialists’ Collaboration. Effects of different blood-pressurelowering regimens on major cardiovascular events: results of prospectively designed overviews.Lancet. 2003;362:1527–1536.
Kannel WB. Cardioprotection and antihypertensive therapy: the key importance of addressing the associated coronary risk factors (the Framingham experience).Am J Cardiol. 1996;77:6B-11B.
Third Report of the National Education Program (NCEP) Expert panel-Adult Treatment Panel III. Bethesda, Md: National Institutes of Health National Heart, Lung, and Blood Institute; 2001. NHLBI-NIH publication, No. 01-3670.
Cifkova R, Erdine S, Fagard R, et al, for the ESH/ESC Hypertension Guidelines Committee. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines.J Hypertens. 2003;21:1779–1786.
Chobanian AV, Bakris GL, Black HR, et al, for the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report.JAMA. 2003;289:2560–2572.
Hagemeister J, Schneider CA, Barabas S, et al. Hypertension guidelines and their limitations: the impact of physicians’ compliance as evaluated by guideline awareness.J Hypertens. 2001; 19:2079–2086.
Mancia G, Volpe R, Boros S, Ilardi M, Giannattasio C. Cardiovascular risk profile and blood pressure control in Italian hypertensive patients under specialist care.J Hypertens. 2004;22:51–57.
Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States.JAMA. 2003;289:2363–2369.
Arroll B, Jenkins S, North D. Non-pharmacological management of hypertension: results from interviews with 100 general practitioners.J Hypertens. 1996;14:773–777.
Fonarow GC. The management of the diabetic patient with prior cardiovascular events.Rev Cardiovasc Med. 2003;4(suppl 6):S38-S49.
UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39.Br Med J. 1998; 17:713–720.
Glaser DN. The controversy of significance testing: misconceptions and alternatives.Am J Crit Care. 1999;8:291–296.
Erdine S. How well is hypertension controlled in Europe?J Hypertens. 2000;18:1348–1349.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malacco, E., Ferri, C., Grandi, A.M. et al. Treatment of hypertension and adherence to treatment guidelines in clinical practice: An Italian study. Adv Therapy 22, 96–106 (2005). https://doi.org/10.1007/BF02849881
Issue Date:
DOI: https://doi.org/10.1007/BF02849881